MADISON SCHATZ: Open Payments
NPI 1003665860 · BISMARCK, ND. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$174 in 9 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $44 · 2025 $174
Food & beverage: $174
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 2 | $37 |
| AstraZeneca Pharmaceuticals LP | 2 | $35 |
| UROGEN PHARMA, INC. | 1 | $31 |
| CSL Behring | 1 | $23 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $21 |
| BioCryst US Sales Co., LLC | 1 | $17 |
| Phathom Pharmaceuticals, Inc. | 1 | $11 |
Products named: DUPIXENT, ZUSDURI, Haegarda, CUVITRU, AIRSUPRA, ORLADEYO, TEZSPIRE, VOQUEZNA.
Industry payments across ND — which companies pay providers there.
